Raynaud's Disease - Overview
Raynaud's disease is characterized by experiencing paralysis or chills of the extremities due to temperature changes or stress. General affected emergency situations include nose, fingers, toes, ears and so on. When a person suffering from Raynaud's disease experiences cold or stress, narrowing of veins and blood vessels reduces blood flow to the limbs. This will reduce the amount of oxygen in the blood, turn into extreme blue or white, feel cold and paralysis. This disease is most common in women, but males may also experience the effects of Raynaud's disease.
Primary pulmonary hypertension (PPH)
Primary pulmonary hypertension occurs as the blood pressure of the pulmonary artery rises and the right side of the heart works out of time to convert carbon dioxide in the blood to oxygen. If the blood pressure is too high, the blood does not receive an adequate amount of oxygen and further contracts the veins and blood vessels. If left untreated, this condition can cause right heart failure. Recently, cases have occurred in PPH after patients started using diet therapies including Fen-Phen. This dangerous drug contracted or contracted the veins and blood vessels of the heart, raising blood pressure. Shortly after these dangerous health complications were discovered, the FDA dropped drugs from the market. But for those already affected by drugs it was too late.
PPH is often treated by the use of beta blockers, ACE inhibitors, diuretics, and oxygen therapy. These treatments attempt to rescue from the right movement itself, by optimizing the left side of the heart. It is best to consult a lawyer if you believe that PPH has been diagnosed and your condition is caused by a weight loss medication or other medication defect. A skilled lawyer will know how best to proceed legal action and can provide necessary guidance.
Link
Studies have suggested that patients with Raynaud's disease are much more likely to develop PPH. Venous and vascular stenosis due to Raynaud's disease is readily helpful in the onset of PPH, regardless of whether Raynaud's patients used weight-reducing drugs including fenfen. No research has yet been done on what happens when people with Raynaud's disease use weight-reducing drugs containing phen-fen, but the science of that condition is that the output is Phen-Fen users.
If you or a loved one suffers from PPH due to the use of weight loss medications or other defective drugs, immediately contact an experienced PPH attorney to discuss your legal rights Please give me.
EmoticonEmoticon